Peripheral Blood Brain-Derived Neurotrophic Factor as a Biomarker of Alzheimer’s Disease: Are There Methodological Biases?

Mounting evidence that alterations in brain-derived neurotrophic factor (BDNF) levels and signaling may be involved in the etiopathogenesis of Alzheimer’s disease (AD) has suggested that its blood levels could be used as a biomarker of the disease. However, higher, lower, or unchanged circulating BD...

Descripción completa

Detalles Bibliográficos
Autores principales: Balietti, Marta, Giuli, Cinzia, Conti, Fiorenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6061178/
https://www.ncbi.nlm.nih.gov/pubmed/29330839
http://dx.doi.org/10.1007/s12035-017-0866-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6061178/
https://www.ncbi.nlm.nih.gov/pubmed/29330839
http://dx.doi.org/10.1007/s12035-017-0866-y

Ejemplares similares